ScRNAseq of EGFR-mut PC9 cells control or treated for 24h or 72h with osimertinib

ABSTRACT: The experiment investigates transcriptional reponse of EGFR-mut PC9 lung cancer cells following treatment for 24h or 72h with EGFR-inhibitor osimertinib compared to control cells on a single cell level.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Homo sapiens

SUBMITTER: Johannes Braegelmann 

PROVIDER: E-MTAB-9468 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress